Royal Bank of Canada boosted its holdings in shares of Ambev S.A. (NYSE:ABEV – Free Report) by 18.1% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 3,700,035 shares of the company’s stock after purchasing an additional 566,949 shares during the period. Royal Bank of Canada’s holdings in Ambev were worth $10,804,000 as of its most recent filing with the SEC.
A number of other institutional investors also recently bought and sold shares of the business. Monument Capital Management purchased a new stake in shares of Ambev in the fourth quarter valued at about $25,000. Integrated Advisors Network LLC acquired a new stake in shares of Ambev during the first quarter worth about $31,000. IHT Wealth Management LLC purchased a new position in shares of Ambev during the fourth quarter worth about $27,000. First Trust Advisors LP purchased a new position in shares of Ambev during the third quarter worth about $25,000. Finally, Integrated Wealth Concepts LLC acquired a new position in Ambev in the 1st quarter valued at about $26,000. 8.13% of the stock is currently owned by institutional investors and hedge funds.
Analyst Ratings Changes
Several research firms have commented on ABEV. UBS Group upped their price objective on Ambev from $2.65 to $2.90 and gave the company a “sell” rating in a research note on Thursday, May 14th. Barclays lifted their target price on Ambev from $3.00 to $3.50 and gave the company an “equal weight” rating in a research note on Wednesday, May 6th. Scotiabank lowered Ambev from a “sector outperform” rating to a “sector perform” rating in a report on Wednesday, July 15th. Weiss Ratings restated a “hold (c+)” rating on shares of Ambev in a research note on Monday, August 3rd. Finally, Wall Street Zen raised Ambev from a “hold” rating to a “buy” rating in a report on Saturday, August 1st. Five research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, Ambev has a consensus rating of “Reduce” and a consensus target price of $3.09.
Ambev Trading Down 0.2%
NYSE ABEV opened at $3.00 on Friday. The stock has a market capitalization of $47.36 billion, a P/E ratio of 15.02, a P/E/G ratio of 2.19 and a beta of 0.65. Ambev S.A. has a 52-week low of $2.10 and a 52-week high of $3.45. The firm has a 50-day moving average price of $3.11 and a 200 day moving average price of $3.05. The company has a quick ratio of 0.76, a current ratio of 1.02 and a debt-to-equity ratio of 0.02.
Ambev (NYSE:ABEV – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $0.04 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.04. Ambev had a return on equity of 17.48% and a net margin of 18.47%.The company had revenue of $3.89 billion for the quarter, compared to analyst estimates of $4.05 billion. Equities research analysts expect that Ambev S.A. will post 0.2 EPS for the current year.
Ambev Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 11th. Investors of record on Wednesday, September 23rd will be issued a dividend of $0.0092 per share. The ex-dividend date of this dividend is Wednesday, September 23rd. This represents a $0.04 dividend on an annualized basis and a yield of 1.2%. Ambev’s payout ratio is currently 15.00%.
Insider Buying and Selling
In related news, Director Ricardo Manuel Frangat Moreira sold 468,040 shares of the business’s stock in a transaction dated Thursday, July 30th. The shares were sold at an average price of $3.08, for a total transaction of $1,441,563.20. Following the sale, the director owned 3,000,000 shares of the company’s stock, valued at approximately $9,240,000. The trade was a 13.50% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.
Ambev Profile
Ambev (NYSE: ABEV) is a Brazilian-based beverage company that produces, distributes and markets a broad portfolio of alcoholic and non-alcoholic drinks. The company’s core business centers on brewing and selling beer, alongside a range of soft drinks, bottled water, energy drinks and other malt-based beverages. Headquartered in São Paulo, Ambev operates an integrated value chain that covers manufacturing, packaging, logistics and commercial sales to retail, on-premise and institutional customers.
The company traces its origins to the 1999 merger of two historic Brazilian breweries, and later became part of the broader global brewing group through subsequent industry consolidations.
Featured Stories
- Five stocks we like better than Ambev
- Quantum Earnings Week: Winners and Losers Are Finally Emerging
- Axon’s Post-Earnings Pullback May Be More About Valuation Than Growth
- Uber Stock Lags in 2026, But Cash Flow and AV Bets Fuel Upside
- AppLovin Stock Hits 52-Week Low as Analysts Trim Targets, Stay Bullish
Want to see what other hedge funds are holding ABEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Ambev S.A. (NYSE:ABEV – Free Report).
Receive News & Ratings for Ambev Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev and related companies with MarketBeat.com's FREE daily email newsletter.
